Clinical Trial Update: Anti-EGFR Agents in Patients With Right-sided Advanced Colorectal Cancer With Wild-type RAS and AREG/EREG High Status [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating anti-EGFR agents in right-sided advanced colorectal cancer with wild-type RAS and high AREG/EREG status is listed as not yet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Gruppo Oncologico del Nord-Ovest | Conditions: Colorectal Cancer | Phase 4 | Status: NOT_YET_RECRUITING